Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion-Reference-Cited by-同舟云学术

Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion

Published:2002-06 Issue:4 Volume:117 Page:935-939
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Kircher Brigitte,Stevanovic Stefan,Urbanek Martina,Mitterschiffthaler Andrea,Rammensee Hans-Georg,Grünewald Kurt,Gastl Günther,Nachbaur David

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03536.x/fullpdf

Reference32 articles.

1. Specific human cellular immunity to bcr-abl oncogene-derived peptides;Bocchia;Blood,1996

2. Donor leukocyte infusions in acute lymphocytic leukemia;Collins, Jr;Bone Marrow Transplantation,2000

3. Donor lymphocyte infusions (Review);Dazzi;Current Opinion in Hematology,1999

4. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens;De Bueger;Journal of Immunology,1992

5. Identification of a graft versus host disease-associated human minor histocompatibility antigen;Den Haan;Science,1995

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy;Frontiers in Immunology;2024-03-15

2. Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia;Best Practice & Research Clinical Haematology;2023-06

3. Transgenic HA-1-Specific CD8+ T-Lymphocytes Selectively Target Leukemic Cells;Cancers;2023-03-03

4. DNA and modified vaccinia Ankara prime–boost vaccination generates strong CD8 + T cell responses against minor histocompatibility antigen HA‐1;British Journal of Haematology;2021-05-28

5. H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect;Frontiers in Immunology;2020-06-10